Importantly, two recent studies have proposed that hyperleptinemia-associated leptin resistance is indeed a driving force for obesity and its associated various metabolic disorders, suggesting that new therapeutic tools to restore leptin sensitivity could offer a new strategy to promote weight loss in obese patients and to treat obesity-associated complications (7, 8). The gene discussed is LEP; the disease is metabolic disease.